What is Acadia Pharmaceuticals's net income?

Acadia Pharmaceuticals (ACAD) reported net income of $3.64M in Q1 2026.

How has Acadia Pharmaceuticals's net income changed year-over-year?

Acadia Pharmaceuticals's net income decreased by 80.8% year-over-year, from $18.99M to $3.64M.

What is the long-term trend for Acadia Pharmaceuticals's net income?

Over 4 years (2021 to 2025), Acadia Pharmaceuticals's net income has grown at a 23.5% compound annual growth rate (CAGR), from -$167.87M to $391M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Acadia Pharmaceuticals ACAD Net Income

Net Income at other companies

BiogenBIIB

$319.5M+32.8%

Neurocrine BiosciencesNBIX

$197.9M+2,405%

Catalyst PharmaceuticalCPRX

$63.73M+12.3%

PTC TherapeuticsPTCT

-$2.81M-100%

BridgeBio PharmaBBIO

-$166.56M+1.8%

TG TherapeuticsTGTX

$19.78M+291%

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$3.64M-80.8%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's net income?: Acadia Pharmaceuticals (ACAD) reported net income of $3.64M in Q1 2026.
How has Acadia Pharmaceuticals's net income changed year-over-year?: Acadia Pharmaceuticals's net income decreased by 80.8% year-over-year, from $18.99M to $3.64M.
What is the long-term trend for Acadia Pharmaceuticals's net income?: Over 4 years (2021 to 2025), Acadia Pharmaceuticals's net income has grown at a 23.5% compound annual growth rate (CAGR), from -$167.87M to $391M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.